John Lepore
CEO
ProFound Therapeutics
ProFound Therapeutics is utilizing high-throughput biological assessment and novel technologies to identify and analyze a vast array of previously undiscovered proteins encoded by the human genome. This expanded understanding of the human proteome enables the development of new therapeutic interventions for a wide range of diseases.
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$87.7MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
The traditional understanding of the human proteome, based on the Human Genome Project, may be incomplete, potentially overlooking a significant number of proteins that could serve as therapeutic targets. Existing drug discovery approaches may be limited by this incomplete knowledge, hindering the development of effective treatments for various diseases.
Solution
ProFound Therapeutics is expanding the known human proteome by identifying and analyzing previously undiscovered proteins encoded in the human genome. The company employs novel technologies to identify the full set of proteins translated by human ribosomes, combined with high-throughput biological assessment to determine their functional roles in health and disease. This expanded understanding of the proteome allows for the identification of new intervention points across many diseases, potentially leading to the development of breakthrough medicines. The Profoundry™ Platform is used to analyze these proteins and elucidate their biological functions, refining the understanding of the molecular underpinnings of human biology and disease.
Target Audience
The primary target audience includes pharmaceutical companies and research institutions seeking novel drug targets and therapeutic interventions for a wide range of diseases.
Features
- Identification of previously undiscovered proteins encoded by the human genome.
- Application of novel technologies to identify the full set of proteins translated by human ribosomes.
- High-throughput biological assessment to uncover the functional roles of novel proteins in health and disease.
- The Profoundry™ Platform for analyzing proteins and elucidating their biological functions.
- Discovery of new intervention points across many diseases.